AstraZeneca and the Hungarian Nephrological Society enter into strategic cooperation
It is estimated that nearly 850 million people worldwide suffer from impaired kidney function and its complications, and all indications are that this will be one of the most threatening diseases in the future. In our country, about one and a half million people can be affected by chronic kidney disease, while depending on their progression, it can increase the risk of cardiovascular damage by up to 14 times.
Related news
Uk medicines authority registers AstraZeneca’s COVID-19 antibody Evusheld
AstraZeneca’s Evusheld has been approved for use by the Medicines…
Read more >U.S. Drug Administration approves long-acting antibody AstraZeneca Evusheld (AZD7442)
AstraZeneca’s Evusheld is a long-acting combination of antibodies (tixagevimab and…
Read more >Related news
“Bite-sized Stories: Tales Without a Leftover” – Nébih announces a story writing competition
The National Food Chain Safety Office (Nébih) has announced its…
Read more >AM: FAO also plays a huge role in overcoming crises affecting the region
International organizations have a major role to play in overcoming…
Read more >Informal consultation of FAO European and Central Asian member countries in Hungary
International organizations have a major role to play in overcoming…
Read more >